CLRB
Price:
$2.03
Market Cap:
$82.35M
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC p...[Read more]
Industry
Biotechnology
IPO Date
2005-11-10
Stock Exchange
NASDAQ
Ticker
CLRB
According to Cellectar Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 57.01M. This represents a change of 16.63% compared to the average of 48.88M of the last 4 quarters.
The mean historical Enterprise Value of Cellectar Biosciences, Inc. over the last ten years is 1.26M. The current 57.01M Enterprise Value has changed 453.65% with respect to the historical average. Over the past ten years (40 quarters), CLRB's Enterprise Value was at its highest in in the March 2024 quarter at 75.56M. The Enterprise Value was at its lowest in in the December 2020 quarter at -28053149.00.
Average
1.26M
Median
1.75M
Minimum
-15533421.00
Maximum
24.84M
Discovering the peaks and valleys of Cellectar Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 24.84M
Minimum Annual Increase = -681.30%
Minimum Annual Enterprise Value = -15533421.00
Year | Enterprise Value | Change |
---|---|---|
2023 | 24.84M | -445.13% |
2022 | -7197342.85 | -681.30% |
2021 | 1.24M | -107.97% |
2020 | -15533421.00 | -316.29% |
2019 | 7.18M | -182.91% |
2018 | -8662349.50 | -193.93% |
2017 | 9.22M | -253.11% |
2016 | -6022800.00 | -365.45% |
2015 | 2.27M | -56.62% |
2014 | 5.23M | -72.05% |
The current Enterprise Value of Cellectar Biosciences, Inc. (CLRB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
6.29M
5-year avg
2.11M
10-year avg
1.26M
Cellectar Biosciences, Inc.’s Enterprise Value is less than Diffusion Pharmaceuticals Inc. (0), greater than Monopar Therapeutics Inc. (-1447403.00), less than Pulmatrix, Inc. (81.10M), greater than Tenax Therapeutics, Inc. (-6183620.00), greater than Bio-Path Holdings, Inc. (6.13M), greater than Catalyst Biosciences, Inc. (-340985.00), greater than Capricor Therapeutics, Inc. (19.42M), less than NextCure, Inc. (839.91M), greater than Longboard Pharmaceuticals, Inc. (21.96M), less than Lumos Pharma, Inc. (2.31B), greater than ImmunoCellular Therapeutics, Ltd. (25.52M), greater than Bolt Biotherapeutics, Inc. (10.21M), greater than Applied Molecular Transport Inc. (38.25M), greater than Aileron Therapeutics, Inc. (-5743713.00), less than Benitec Biopharma Inc. (64.72M), less than null (163.42M),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $8.98M | |
-1447403.00 | $87.22M | |
81.10M | $7.59M | |
-6183620.00 | $15.24M | |
6.13M | $3.61M | |
-340985.00 | $19.42M | |
19.42M | $845.38M | |
839.91M | $36.65M | |
21.96M | $2.32B | |
2.31B | $35.87M | |
25.52M | $10.21M | |
10.21M | $25.56M | |
38.25M | $11.01M | |
-5743713.00 | $86.66M | |
64.72M | $214.00M | |
163.42M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectar Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cellectar Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cellectar Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cellectar Biosciences, Inc. (CLRB)?
What is the 3-year average Enterprise Value for Cellectar Biosciences, Inc. (CLRB)?
What is the 5-year average Enterprise Value for Cellectar Biosciences, Inc. (CLRB)?
How does the current Enterprise Value for Cellectar Biosciences, Inc. (CLRB) compare to its historical average?